GalNAc-T6, a key enzyme within the UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase family, holds a pivotal role in the post-translational modification of proteins through O-glycosylation. This enzymatic process involves the addition of N-acetylgalactosamine to serine or threonine residues of target proteins, thereby influencing their function, stability, and localization within the cell. GalNAc-T6-mediated glycosylation plays a crucial role in various cellular processes, including cell adhesion, signaling, and protein trafficking. By modifying protein structures, GalNAc-T6 contributes to the regulation of diverse physiological and pathological pathways, highlighting its significance in cellular homeostasis and disease progression.
Activation of GalNAc-T6 involves intricate regulatory mechanisms that ensure precise control over its enzymatic activity. These mechanisms can be modulated by various factors, including cellular signaling pathways, transcriptional regulators, and post-translational modifications. Signaling cascades initiated by extracellular stimuli, such as growth factors or cytokines, can converge on GalNAc-T6, either directly or indirectly, influencing its activity through phosphorylation events or changes in its subcellular localization. Additionally, transcriptional regulators may modulate the expression levels of GalNAc-T6 in response to environmental cues or developmental signals, thereby altering its availability for substrate binding and catalysis. Furthermore, post-translational modifications, such as glycosylation or protein-protein interactions, can regulate the enzymatic activity of GalNAc-T6, fine-tuning its function in a context-dependent manner. Overall, the activation of GalNAc-T6 is tightly regulated by a complex interplay of cellular processes, reflecting its importance in cellular physiology and disease pathology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Involved in cell differentiation and proliferation. Can influence pathways that modify GALNT6 expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates intracellular cAMP levels, affecting cell signaling pathways that might indirectly modulate GALNT6 activity. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid affecting numerous cellular pathways. May indirectly influence GALNT6 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK3β, a kinase with broad cellular roles. Might indirectly modulate GALNT6 through this inhibition. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C. By regulating PKC-mediated signaling, it might indirectly affect GALNT6. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Affects gene expression patterns. Can potentially influence GALNT6 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylase, thus affecting chromatin structure. This can indirectly influence GALNT6 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can affect various cellular processes, possibly influencing GALNT6 indirectly. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-κB pathway. This inhibition might have a downstream effect on GALNT6. | ||||||